Alembic Pharmaceuticals consolidated net profit declines 35.73% in the June 2017 quarter
Sales decline 12.03% to Rs 648.19 crore
Net profit of Alembic Pharmaceuticals declined 35.73% to Rs 66.67 crore in the quarter ended June 2017 as against Rs 103.74 crore during the previous quarter ended June 2016. Sales declined 12.03% to Rs 648.19 crore in the quarter ended June 2017 as against Rs 736.80 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales648.19736.80 -12 OPM %15.6521.30 -PBDT100.69156.28 -36 PBT78.85136.90 -42 NP66.67103.74 -36Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content